




Colorectal cancer (CRC) is one of the most com-
mon cancers in industrialized countries and it 
represents one of the leading causes of cancer-
related morbidity and mortality. The incidence 
rates for CRC vary among different groups and 
populations depending on race, gender and 
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Abstract: Colorectal cancer (CRC) is a complex disease related to environmental and genetic risk factors. Several 
studies have shown that susceptibility to complex diseases can be mediated by ancestral alleles. Using RNAi screen-
ing, CTNNBL1 was identified as a putative regulator of the Wnt signaling pathway, which plays a key role in colorectal 
carcinogenesis. Recently, single nucleotide polymorphisms (SNPs) in CTNNBL1 have been associated with obesity, a 
known risk factor for CRC. We investigated whether genetic variation in CTNNBL1 affects susceptibility to CRC and 
tested for signals of recent selection. We applied a tagging SNP approach that cover all known common variation in 
CTNNBL1 (allele frequency >5%; r²>0.8). A case-control study was carried out using two well-characterized study 
populations: a hospital-based Czech population composed of 751 sporadic cases and 755 controls and a family/
early onset-based German population (697 cases and 644 controls). Genotyping was performed using allele specific 
PCR based TaqMan® assays (Applied Biosystems, Weiterstadt, Germany). In the Czech cohort, containing sporadic 
cases, the ancestral alleles of three SNPs showed evidence of association with CRC: rs2344481 (OR 1.44, 95%CI 
1.06-1.95, dominant model), rs2281148 (OR 0.59, 95%CI 0.36-0.96, dominant model) and rs2235460 (OR 1.38, 
95%CI 1.01-1.89, AA vs. GG). The associations were less prominent in the family/early onset-based German cohort. 
Data derived from several databases and statistical tests consistently pointed to a likely shaping of CTNNBL1 by posi-
tive selection. Further studies are needed to identify the actual function of CTNNBL1 and to validate the association 
results in other populations. 
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age. The highest incidence rate can be found in 
New Zealand, Australia, North America, Europe 
and more recently in Japan, whereas lower 
rates are reported in Asia and Africa [1, 2]. Sev-
eral non-genetic factors, such as nutrition, life 
style and environment [3], as well as genetic 
variation, reflected by familial aggregation and 
identified high- and low-penetrance mutations 
[4, 5], contribute to the risk of developing CRC. 
Inherited susceptibility underlies ~35% of vari-
ance in colorectal cancer risk [6]. Yet, high-
penetrance germline mutations, such as mis-
match repair genes and adenomatous polyposis 
coli (APC) mutations, only account for less than 
5% of all CRC cases but they contribute to  the 
heritability of CRC in general [4, 5, 7, 8]. In com-
parison, low-penetrance mutations contribute to 
a small proportion of familial cases and to a 
larger proportion of sporadic cases [4, 5, 8].  
 
The CTNNBL1 [catenin (cadherin-associated 
protein) b-like 1] (GeneID: 56259) gene was 
newly identified using RNAi screening as a puta-
tive regulator of the canonical Wnt signaling 
pathway, acting upstream of, or in parallel to β-
catenin (D.I. and M.B., unpublished data). Liu et 
al. have also connected CTNNBL1 to Wnt signal-
ing through structural homologies of CTNNBL1 
to β-catenin, the main mediator in the Wnt path-
way [9]. Wnt signaling plays an important role in 
cell proliferation, differentiation and stem cell 
maintenance during embryonic development 
and tissue renewal in adult organisms. Impor-
tantly, dysregulation of Wnt signaling, mainly 
through mutations of the pathway components, 
plays a key role in colorectal carcinogenesis  
[10]. Moreover, nutrition related diseases, such 
as obesity and type 2 diabetes, are affected by 
genetic and functional variations in the Wnt 
signaling pathway [11]. Single nucleotide poly-
morphisms (SNPs) in CTNNBL1 have been asso-
ciated with increased body mass index (BMI) 
and fat mass in case-control studies of different 
populations [9, 12, 13]. Obesity, high BMI and 
high fat mass are also known risk factors for the 
development of CRC. Taken together, these 
facts suggest that CTNNBL1 may be involved in 
CRC and other nutrition related diseases if mu-
tated or dysregulated. 
 
Nutrition related traits are common targets for 
selection and local adaptation [14, 15]. Several 
diseases, such as obesity, type 2 diabetes and 
hypertension, have been linked to polymor-
phisms in which the ancestral allele increases 
the risk of the disease [16]. This kind of allelic 
effect is described as the ancestral-
susceptibility model [16]. Such polymorphisms 
frequently show significant differences in the 
worldwide allele distribution. In the case of non-
synonymous polymorphisms, it is usually 
straightforward to describe the cause and the 
direction of selective pressure due to the al-
tered function, whereas in the case of non-
coding, low-penetrance polymorphisms, com-
plex processes and interactions may cause the 
final phenotype. Especially in complex diseases, 
the detected effect of a low-penetrance poly-
morphism may point an undiscovered interme-
diate phenotype or it might have developed due 
to selection of another trait linked to the ana-
lyzed one [17].  
 
We considered CTNNBL1 as a promising candi-
date gene to be associated with CRC. We inves-
tigated whether genetic variation in CTNNBL1 
affects the susceptibility to CRC and searched 
for signals of selective pressure on this particu-
lar gene.  
 




In this project, two case-control studies were 
carried out, one containing newly diagnosed, 
incident cases from the Czech Republic, the 
other familial cases from Germany. The first 
population was a hospital-based sample set 
from the Czech Republic. DNA extracts from 
peripheral leukocytes from the Czech study par-
ticipants were collected between December 
2004 and December 2007 [18]. The CRC case 
group contained 751 patients recruited in nine 
oncological departments in the Czech Republic 
(two in Prague, one each in Benesov, Brno, 
Liberec, Ples, Pribram, Usti nad Labem and 
Zlin). The patients showed positive colonoscopic 
results for malignancy, histologically confirmed 
as colon or rectal carcinomas. Patients who met 
the Amsterdam criteria I and II for hereditary 
nonpolyposis colorectal cancer (HNPCC) [19] 
were not included in the study population. The 
control group contained 755 individuals that 
underwent colonoscopy for various gastrointes-
tinal complaints, such as macroscopic bleeding, 
positive fecal occult blood test (FOBT) or ab-
dominal pain of unknown origin, in five gastro-
enterological departments of the Czech Repub-
lic (Prague, Brno, Jihlava, Liberec and Pribram). 
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Both the case and the control populations rep-
resent the entire Czech Republic. Only individu-
als with negative colonoscopic results for malig-
nancies, colorectal adenomas, benign polyps or 
inflammatory bowel disease (IBD) were chosen 
for the control group. Beside general informa-
tion about gender and age, information about 
BMI was available for the majority of individuals 
(61.7% of the case population and 69.1% of the 
control population). Additionally, similar propor-
tion of the study participants provided informa-
tion about their diabetes status (62% of the 
case population and 70% of the control popula-
tion). All data about the individuals were col-
lected at the time of diagnosis for cases and at 
the time of sampling for controls. Table 1 out-
lines the available characteristics of the Czech 
study population at the time of recruitment. 
 
The SNPs which showed significant results in 
the Czech population were additionally analyzed 
in a German sample set based on familial CRC 
cases. Blood samples from the 697 German 
cases were collected as part of a large study on 
susceptibility to HNPCC [20] and they were re-
cruited by six German university hospitals 
(Bochum, Bonn, Dresden, Düsseldorf, Heidel-
berg and Munich/Regensburg). All case patients 
fulfilled Bethesda Guidelines to be screened for 
HNPCC [21]. The patients selected for this case-
control study were all found to be microsatellite 
stable and therefore negative for germ line mu-
tations in MSH2 and MLH1 through systematic 
screening [20]. Additionally, only patients with 
at least one first degree relative affected by CRC 
(62.4% of the cases) or patients diagnosed be-
low the age 50 years (33.6%) were included to 
the study. For 4% of the cases, the inclusion 
criterion was missing. The cases eligible for the 
study were unrelated. Data regarding the BMI 
and diabetes status were not available. The 
control population was composed of 672 
healthy, unrelated and ethnicity-, gender- and 
age-matched German blood donors who were 
recruited between 2004 and 2006 by the Insti-
tute of Transfusion Medicine and Immunology, 
University of Mannheim, Germany [22]. Table 1 
outlines the available characteristics of the Ger-





Several databases were used to investigate 
distinct characteristics of CTNNBL1. The degree 
of overall conservation was measured by Pu-
 
Table 1. Characteristics of the study populations at the time of diagnosis for cases and at the time of 
sampling for controls 
Czech population Cases Controls p value 
total 751 755   
male [n (%)] 418 (56%) 446 (59%) 0.50 
female [n (%)] 311 (41%) 309 (41%)   
missing gender [n (%)] 22 (3%) 0   
median age [range] 60.8 [27-85] 54.4 [28-91] <0.001 
missing age [n (%)] 23 (3%) 0   
median BMI [range] 27 [13-53] 27 [17-44] 0.49 
missing BMI [n (%)] 288 (38%) 233 (31%)   
diabetes [n (%)] 78 (10%) 58 (8%) 0.01 
no diabetes [n (%)] 391 (52%) 468 (62%)   
missing diabetes information [n (%)] 282 (38%) 229 (30%) 0.003* 
German population Cases Controls   
total 697 672   
male [n (%)] 348 (50%) 288 (43%) 0.01 
female [n (%)] 349 (50%) 384 (57%)   
missing gender [n (%)] 3 (0%) 0   
median age [range] 44 [9-82] 44 [26-68] <0.001 
missing age [n (%)] 30 (4%) 0   
BMI, body mass index; *”with” compared to “without” self-reported diabetes information. 
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pasuite 2.0.0 using BLASTZ [23], information 
about the LD/r² of all tagSNPs and captured 
SNPs were obtained from HapMap Genome 
Browser (HapMap3; release #2, Phase 3; 
http://hapmap.ncbi.nlm.nih.gov;) [24] and the 
recombination rate and the regulatory potential 
were analyzed using UCSC Genome Browser on 
Human (Mar. 2006 Assembly; hg18) [25-27].  
 
Phylogenetic trees of the coding DNA (cDNA) 
sequences and intronic DNA sequences of dif-
ferent species were created with the program 
SplitsTree V4.10 [28]. The sequences of Homo 
sapiens sapiens, Pan troglodytes, Pongo pyg-
maeus, Macaca mulatta, Mus musculus, Rattus 
norvegicus, Bos Taurus, Equus freus caballus, 
Canis lupus familiaris and Monodelphis domes-
tica gained from the Ensembl Genome Browser 
[29] were aligned using MEGA4 software [30]. 
For the cDNA, the sequence of Gallus gallus 
domesticus was additionally used for alignment. 
The sequence alignments were utilised to calcu-
late phylogenetic consensus trees using the 
neighbour joining method and to calculate boot-
strap values (SplitsTree V4.10). In the resulting 
trees, taxa are represented by nodes and their 
evolutionary relationships are represented by 
branches. A group of species that includes all 
descendants of one common ancestor is a de-
nominated clade. Bootstrap values indicate how 
reliable a clade is [31]. 
 
Selection of SNPs 
 
This study focused on SNPs within the CTNNBL1 
gene region. Eight unlinked tagging SNPs 
(tagSNPs) with a minor allele frequency (MAF) ≥ 
5% were selected using the genotyping data of 
the CEU population in HapMap (NCBI dbSNP35) 
(rs6067377, rs2344481, rs238302, 
rs2281148, rs6067889, rs4811233, 
rs6067923) [24]. These tagSNPs represent a 
total of 123 SNPs annotated in the NCBI dbSNP 
(http://www.ncbi.nlm.nih.gov) encompassing 
the whole gene including 1.9kb up- and 1.1kb 
downstream of the first and the last exonic 
base, respectively (r² value of LD >0.8). Includ-
ing the captured SNPs, all polymorphisms were 
located in the non-coding regions of the 
CTNNBL1 gene. The tagSNP selection was per-





Multiple statistical methods and databases 
were used to investigate the characteristics of 
the SNPs selected for the tagSNP approach. The 
worldwide allele distribution of the eight 
tagSNPs and all the 123 captured SNPs was 
analyzed for differences among the Caucasian 
population (CEU, Utah residents with Northern 
and Western European ancestry from the CEPH 
collection), the Sub-Saharan African population 
(YRI, Yoruba in Ibadan, Nigeria) and the East 
Asian population (HCB, Han Chinese in Beijing, 
China, and JPT, Japanese in Tokyo, Japan). The 
frequency data were derived from the NCBI da-
tabase (http://www.ncbi.nlm.nih.gov) using the 
data available for the Submitter Population IDs: 
HapMap -CEU, -YRI, -HCB and -JPT.  
 
Based on this data the Fixation indexes (FST val-
ues) and the corresponding probability values 
were estimated for the CRC associated SNPs 
(rs2344481, rs2281148 and rs2235460) us-
ing the Arlequin 3.1 Software [32]. FST values > 
0.25 indicate strong genetic differentiation (i.e. 
the SNPs might have been targets of selection); 
FST values in the range of 0.05 to 0.1 indicate 
moderate genetic differentiation [33]. FST p val-
ues ≤ 0,05 are generally considered to be evolu-
tionarily significant [34].  
 
Further, the Haplotter database was used to 
investigate additional parameters that reflect 
selective processes in CTNNBL1. In lack of di-
rectly available information about the SNP that 
showed the strongest association with CRC risk 
(rs2344481) we used data of six SNPs captured 
by rs2344481 (r²>0.8) (rs6020395, 
rs6021428, rs6020712, rs6125962, 
rs6020846, rs6512695). Strong negative Fay-
Wu's H were considered as signatures for a se-
lective sweep [35, 36]; iHS  < −1.5 and > 1.5 
give conclusive evidence for natural selection 
and iHS < −2 or > 2 give evidence for a powerful 
selection signal [17, 36]. Additionally, the de-
rived allele frequencies of the six SNPs captured 
by rs2344481 were used as markers for the 
worldwide allele distribution, providing further 




Genotype analyses were performed using allele 
specific PCR based TaqMan assays, designed 
by Applied Biosystems (Applied Biosystems, 
Weiterstadt, Germany). PCR reactions were car-
ried out using 5ng purified DNA per reaction. 
Thermo cycling was performed according to the 
Applied Biosystems PCR conditions with 35 to 
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50 cycles (depending on optimal performance). 
The genotyping was performed simultaneously 
for case- and control- samples. The genotype 
detection was performed using an ABI PRISM 
7900 HT Sequence Detection System with SDS 
2.2 software (Applied Biosystems, Weiterstadt, 
Germany). Direct sequencing was used to ran-
domly control genotypes determined by TaqMan 
assays and to reveal the actual genotype of 
samples with an unclear classification by 
TaqMan assays. PCR amplification and se-
quencing reaction were performed as described 
in [37].  
 
Statistical analysis of the genotyping data 
 
The observed genotype frequencies in the con-
trols were tested for Hardy-Weinberg equilib-
rium (HWE) and differences between the ob-
served and the expected frequencies were 
tested for significance using χ² tests. 
 
Statistical significance for different genotype 
distributions in cases and controls were deter-
mined by global χ² tests. The overall genotype 
effect of a SNP on the risk of CRC was consid-
ered statistically significant at the level p ≤ 
0.05. Odds ratios (ORs) and 95% confidence 
intervals (95% CIs) for association between 
genotypes and CRC risk were estimated based 
on logistic regression (PROC LOGISTIC, SAS Ver-
sion 9.1; SAS Institute, Cary, NC). The calculated 
effects referred to the ancestral allele. Besides 
raw genotype effects, ORs were also adjusted 
for age, gender, nationality and BMI (age: conti-
nous variable, BMI: grouped according to BMI 
<20; 20-24; 25-30; 30-35; 35-40; >40) since 
age, gender and BMI are the most important 
factors contributing to the risk of CRC. 
 
Genotypes of SNPs in the ±500kb region 
around the genotyped polymorphisms were im-
puted based on the HapMap data of the CEU 
population, in order to detect possible associa-
tions with non-genotyped SNPs. Multiple impu-
tation relied on inference of haplotypes by 
means of the expectation–maximization (EM) 
algorithm in the presence of partially missing 
genotypes. In brief, missing alleles were ex-
cluded from the calculation of allele frequen-
cies. In the E-step, frequencies of partially miss-
ing genotypes were updated looping through all 
possible genotypes. In the M-step, all existing 
haplotypes that have alleles identical to the non
-missing alleles of this haplotype were updated. 
The accuracy of imputation based on HapMap 
was evaluated by cross-validation, and it was 
represented by minus the logarithm of the prob-
ability value for Cohen’s Kappa between true 
and imputed genotypes. Uncertainty in the im-
puted genotypes was taken into account in the 
subsequent logistic regression by bootstrapping 
from the multinomial distribution of the ex-
pected genotypes given the observed, directly 
genotyped variants (1,000 replicates). Probabil-
ity values referred to a model-free, three-




Signatures of positive selection in CTNNBL1  
 
The analyses of the linkage disequilibrium (LD) 
[24] and the recombination rate [27] indicated 
a high conservation of CTNNBL1. By the use of 
only eight tagSNPs, it was possible to analyze 
123 SNPs (annotated in the NCBI dbSNP35; 
MAF>0.05, mean r²=0.95), encompassing the 
whole gene and the neighbouring regions 1,9 kb 
upstream and 1,1 kb downstream of the first 
and last exonic base, respectively (35,754kb-
35,936kb) [24]. The average recombination 
rate in this region was very low, especially in 
males (0.0-0.7 in males, 1.5-2.7 in females). 
Furthermore, the regulatory potential of the 
CTNNBL1 sequence was estimated as high, 
encompassing the whole gene. The mean value 
of ESPERR Regulatory Potential within a se-
quence range from 35,755,848 to 35,933,934 
was estimated to be 0.06 [25, 26]. In general, 
the range of the regulatory potential scores 
from 0.0 (low) to 0.1 (high).  
 
Next to these characteristics, the database 
analysis showed a high degree of interspecific 
conservation (60.3%) within the gene region. 
This estimation refers to the comparison of the 
human-mouse alignment (Pupasuite 2.0.0 - Bio-
info 2008. CIPF; using BLASTZ) [23]. Maximal 
extent of the region analyzed was 35,754kb-
35,939kb and contained both coding and in-
tronic gene regions. Within this region 553 out 
of 917 SNPs were found to be unique. Ensem-
ble reports this gene in 36 different species 
including zebrafish and chicken next to various 
mammalian species (http://www.ensembl.org). 
Besides the similarities within the analysed spe-
cies the differences were species specific and 
were used to construct phylogenetic trees. 
 
The phylogenetic analysis of the cDNA se-
quences of CTNNBL1 provided further evidence 
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about the location of the gene in a highly con-
served gene region. The algorithm resulted in a 
highly resolved phylogenetic tree that reflected 
one of the today's valid phylogenetic trees of 
animals [38] (Figure 1). The analysis of intronic 
sequences of CTNNBL1 showed a phylogenetic 
tree that resembled the cDNA tree on many 
points. In Figure 2 the phylogentic tree of intron 
3 is shown as an example. The order- and spe-
cies-clades were equally well dissolved in the 
intronic tree as in the cDNA tree. In the case of 
the primates-clade it fitted the today's valid phy-
logenetic tree even better than the cDNA tree. 
Both trees failed in resolving the Laurasiatheria 
and Euarchontoglires clade [38].  
 
The analysis of the allele frequencies of the 
tagSNPs selected for the study showed distinct 
differences among the three populations ana-
lyzed by the International HapMap Project (YRI, 
CEU, HCB and JPT) [24]. The frequencies of the 
ancestral alleles declined from the YRI to the 
CEU and the HCB/JPT populations in about half 
of the SNPs captured in this study (60/123). 
The strongest decline in the ancestral allele 
frequency was found in tagSNP rs2344481 and 
in SNPs captured by it. The ancestral allele of 
rs2344481 was the major allele in YRI (52%) 
and the minor allele in CEU (5%), JPT (4.7%) and 
HCB (0%). 
 
To investigate whether SNPs in CTNNBL1 might 
have been targets of selection, we further inves-
tigated three parameters: FST, Fay-Wu's H and 
iHS. The FST statistics showed values above 
0.25 for rs2344481 and rs2281148 in the 
comparison of the African population with the 
three non-African populations indicating strong 
genetic differentiation (Table 2). For 
rs2235460, the comparison of the African and 
the Japanese population showed moderate ge-
netic differentiation (FST value 0.05). A moder-
ate genetic differentiation was also found for 
rs2344481 (European vs. Chinese) and 
rs2281148 (European vs. Chinese). The FST p 
values were statistically significant for 
rs2344481 and rs2281148 in the comparison 
of the African population with the three non-
African populations and for rs2239460 in the 
comparison of the African population to the Chi-
nese and Japanese populations, indicating evo-
lutionary significance. To investigate the two 
Figure 1. Phylogenetic tree of 
the cDNA sequence of 
CTNNBL1. Different taxa are 
represented by nodes and 
their evolutionary relation-
ships are represented by 
branches. Bootstrap values 
indicate how reliable a clade 
is. 
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other parameters, Fay-Wu's H and iHS, we used 
data of six SNPs (rs6020395, rs6021428, 
rs6020712, rs6125962, rs6020846, 
rs6512695) captured by rs2344481, the SNP 
with strongest association with CRC, because 
no direct information about rs2344481 was 
available (Table 3). All six SNPs showed strong 
negative Fay-Wu's H with a sizeable decrease 
from the YRI via the CEU to the ANS (East 
Asians) population indicating a selective sweep. 
Figure 2. Phylogenetic tree of 
the intronic DNA (intron3) 
sequence of CTNNBL1. Dif-
ferent taxa are represented 
by nodes and their evolution-
ary relationships are repre-
sented by branches. Boot-
strap values indicate how 
reliable a clade is. All tested 
introns gave similar phyloge-
netic trees as intron 3, exem-
plarily shown here. 
 
 
Table 2. Fixation index (FST estimates with probability values in brackets) for CRC associated SNPs among 
African, European, Chinese and Japanese population 
Population   African European Chinese Japanese 
rs2344481 
African *       
European 0.50 (<0.001) *     
Chinese 0.61 (<0.001) 0.07 (<0.001) *   
Japanese 0.49 (<0.001) -0.01 (0.80) -0.08  (<0.001) * 
rs2281148 
African *       
European 0.36 (<0.001) *     
Chinese 0.55 (<0.001) 0.10 (<0.001) *   
Japanese 0.54 (<0.001) 0.04 (<0.001) 0.02 (0.06) * 
rs2235460 
African *       
European 0.04 (0.02) *     
Chinese -0.01 (0.59) 0.03 (0.02) *   
Japanese 0.05 (<0.001) -0.01 (0.95) 0.05 (0.02) * 
Bold numbers indicate strong/moderate genetic differentiation at 5% statistical significance. 
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Two SNPs (rs6020395 and rs6125962) 
showed an iHS >1.5 giving suggestive evidence 
for natural selection. Additionally, four SNPs 
(rs6020395, rs6020712, rs6020846, 
rs6125962) showed a distinct rise of the de-
rived allele frequency up to 52% from the YRI 
via the CEU to the ANS population, providing 
further evidence for a selective sweep (Table 3). 
 
Case-control study  
 
Czech population - sporadic CRC 
 
The genotype distribution of all eight tagSNPs 
measured in the Czech control population was 
according to Hardy-Weinberg equilibrium (HWE) 
and the allele frequencies did not differ signifi-
cantly from the allele frequencies for the Cauca-
sian population given in the NCBI database 
(http://www.ncbi.nlm.nih.gov/). Therefore, it 
was feasible to use the NCBI data for the phy-
logenetic investigation. 
 
Three tagSNPs were found to be statistically 
significantly associated with CRC: rs2344481 
(OR 1.44, 95% CI 1.06-1.95, dominant model), 
rs2281148 (OR 0.59, 95% CI 0.36-0.96, domi-
nant model) and rs2235460 (OR 1.38, 95% CI 
1.01-1.89, derived allele homozygote vs. ances-
tral allele homozygote) (Table 4). The analysis of 
the data using a recessive model was also con-
ducted and yielded no significant results (data 
not shown). After the adjustment of the data for 
age and for age, gender and BMI in the sub-
group of individuals with data of BMI, only 
rs2344481 showed a statistically significant 
association with CRC (OR 1.38, 95% CI 1.00-
1.91; dominant model and OR 1.55, 95% CI 
1.01-2.36; dominant model, respectively).  
 
The imputation of genotypes based on HapMap 
data revealed three SNPs with a lower p value 
than rs2344481: rs6012770 (p 0.02; MAF 
0.08; ~18kb upstream of CTNNBL1), rs928199 
(p 0.02; MAF 0.05; ~16kb upstream of 
CTNNBL1) and rs6096781 (p 0.02; MAF 0.08; 
~30kb downstream CTNNBL1). These three 
SNPs are in high LD with rs2344481 
(rs6012770: r² 0.9, rs928199: r² 0.95, 
rs6096781: r² 0.7).   
 
German population - familial CRC 
 
In order to analyze whether the SNPs affecting 
sporadic CRC risk would also affect the risk of 
familial/early onset CRC, we genotyped three 
SNPs (rs2344481, rs2281148, rs2235460) in 
the German sample set, with familial/early on-
set CRC cases. The allele frequencies of the 
tested SNPs did not differ significantly from the 
 
Table 3. Haplotter Data for SNPs captured by rs2344481 (r²>0.8) 
rs6020395 YRI CEU ANS   rs6021428 YRI CEU ANS 
Derived allele 
frequency 0.467 0.933 0.978   
Derived allele 
frequency 0.083 0.058 0.011 
Standardized iHS 1.626 0.984 -0.232   Standardized iHS -0.117 -0.957 - 
Fay-Wu's H -1.417 -7.631 -25.785   Fay-Wu's H -11.649 -13.473 -29.167 
rs6020712 YRI CEU ANS   rs6125962 YRI CEU ANS 
Derived allele 
frequency 0.717 0.950 0.989   
Derived allele 
frequency 0.458 0.933 0.978 
Standardized iHS 0.345 1.051 -   Standardized iHS 1.860 0.730 - 
Fay-Wu's H -21.846 -36.428 -72.758   Fay-Wu's H -19.302 -37.773 -83.117 
rs6020846 YRI CEU ANS   rs6512695 YRI CEU ANS 
Derived allele 
frequency 0.717 0.933 0.989   
Derived allele 
frequency 0.242 0.067 0.011 
Standardized iHS 0.420 0.391 -   Standardized iHS 0.159 0.138 - 
Fay-Wu's H -11.749 -36.683 -69.796   Fay-Wu's H -11.258 -35.959 -65.078 
iHS integrated Haplotype Score; YRI Yoruba in Ibadan, Nigeria; CEU, Utah residents with Northern and Western Euro-
pean ancestry from the CEPH collection; ANS combined Asian Population. 
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Table 4. Genotype distributions and estimated risk of the ancestral allele of the polymorphisms in CTNNBL1 in the hospital-based Czech sample 
population: unadjusted and age adjusted results 
SNP Allelea Sample Genotype distribution Codominat Model Dominant Model 
   DD-DA-AA DD vs DA DD vs AA DD vs DA+AA 
   Cases Controls OR 95% CI P OR 95% CI P OR 95% CI P 
rs6067377 T/C all samples 252-368-127 
266-360-
115 1.08 0.86-1.35 0.51 1.17 0.86-1.58 0.33 1.10 0.89-1.36 0.38 
  adjusted for age 240-359-125 
266-360-
115 1.11 0.87-1.41 0.42 1.12 0.81-1.54 0.50 1.11 0.88-1.39 0.39 
rs2344481 A/G all samples 628-112-2 658-80-3 1.47 1.08-1.99 0.01 0.70 0.12-4.19 0.69 1.44 1.06-1.95 0.02 
  adjusted for age 606-111-2 658-80-3 1.40 1.01-1.94 0.04 0.77 0.12-5.09 0.79 1.38 1.00-1.91 0.05 
rs238302 A/G all samples 82-335-327 85-330-324 1.05 0.75-1.48 0.77 1.05 0.75-1.47 0.79 1.05 0.76-1.45 0.77 
  adjusted for age 82-335-327 85-330-324 1.12 0.78-1.61 0.54 1.09 0.76-1.57 0.63 1.11 0.79-1.56 0.56 
rs2281148 C/T all samples 45-242-457 27-237-478 0.61 0.37-1.02 0.06 0.57 0.35-0.94 0.03 0.59 0.36-0.96 0.03 
  adjusted for age 42-234-445 27-237-478 0.64 0.37-1.10 0.11 0.62 0.37-1.05 0.08 0.63 0.37-1.05 0.08 
rs2235460 A/G all samples 100-349-270 
124-368-
243 1.18 0.87-1.59 0.29 1.38 1.01-1.89 0.05 1.26 0.94-1.67 0.12 
  adjusted for age 96-342-262 124-368-243 1.16 0.83-1.61 0.38 1.29 0.92-1.82 0.14 1.21 0.89-1.66 0.22 
rs6067889 A/G all samples 448-262-32 448-255-30 1.03 0.83-1.28 0.81 1.07 0.64-1.79 0.81 1.03 0.84-1.27 0.77 
  adjusted for age 432-257-30 448-255-30 1.07 0.85-1.36 0.55 1.10 0.63-1.92 0.75 1.08 0.86-1.35 0.52 
rs4811233 C/G all samples 358-295-80 378-265-81 1.18 0.94-1.47 0.15 1.04 0.74-1.47 0.81 1.14 0.93-1.41 0.20 
  adjusted for age 343-289-78 378-265-81 1.20 0.96-1.50 0.10 1.06 0.75-1.50 0.74 1.17 0.95-1.44 0.14 
rs6067923 G/Ab all samples 339-322-84 356-291-81 1.16 0.94-1.44 0.18 1.09 0.78-1.53 0.62 1.15 0.93-1.41 0.19 
  adjusted for age 330-331-79 356-291-81 1.23 0.99-1.53 0.07 1.05 0.75-1.48 0.77 1.19 0.97-1.46 0.10 
OR odds ratio; CI confidence interval; A ancestral allele, D derived allele.  a Second allele represents the ancestral allele for each locus. b  ancestral allele unknown, the 
major allele was used as reference. Total numbers of cases and controls may slightly vary among SNPs due to missing genotypes. Bold numbers indicate statistical 
significance at 5% level. The results were adjusted for age due to significant difference in the median age distribution among the case and the control group. 
 
  
Polymorphisms in CTNNBL1 
  
 







      
Table 5. Genotype distributions of the polymorphisms in CTNNBL1 in the hospital-based Czech and the family/early onset-based German sample 
population showing combined results adjusted for age, gender and nationality 
SNP Allelea Sample Genotype distributionb Codominat Model Dominant Model 
   DD-DA-AA DD vs DA DD vs AA DD vs DA+AA 
   Cases Controls OR 95% CI P OR 95% CI P OR 95% CI P 
rs2344481 A/G 
Czech 606-111-2 658-80-3 1.47 1.07-2.02 0.02 0.82 0.13-5.29 0.84 1.45 1.06-1.98 0.02 
German 561-81-4 554-69-4 1.16 0.82-1.63 0.40 0.95 0.23-3.83 0.94 1.15 0.82-1.61 0.42 
Czech & German 1167-192-6 1212-149-7 1.34 1.06-1.68 0.01 0.99 0.33-2.98 0.98 1.32 1.05-1.66 0.02 
rs2281148 C/T 
Czech 42-234-445 27-237-478 0.60 0.35-1.03 0.06 0.57 0.34-0.95 0.03 0.58 0.35-0.97 0.04 
German 37-199-418 41-212-408 1.08 0.66-1.76 0.76 1.15 0.72-1.83 0.57 1.12 0.71-1.77 0.64 
Czech & German 79-433-863 68-449-886 0.81 0.56-1.15 0.23 0.83 0.59-1.16 0.27 0.82 0.59-1.15 0.25 
rs2235460 A/G 
Czech 96-342-262 124-368-243 1.20 0.89-1.65 0.26 1.39 1.00-1.93 0.05 1.28 0.95-1.72 0.11 
German 97-302-207 120-311-214 1.21 0.88-1.65 0.24 1.19 0.86-1.66 0.30 1.20 0.89-1.61 0.22 
Czech & German 193-644-469 244-679-457 1.21 0.97-1.51 0.09 1.31 1.04-1.65 0.02 1.25 1.01-1.54 0.04 
OR odds ratio; CI confidence interval; A ancestral allele, D derived allele.  a Second allele represents the ancestral allele for each locus. Total numbers of cases and 
controls may slightly vary among SNPs due to missing genotypes. Bold numbers indicate statistical significance at 5% level. The results were adjusted for age due to 
significant difference in the median age distribution among the case and the control group. 
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allele frequencies of the Caucasian population 
given in the NCBI database (http://
www.ncbi.nlm.nih.gov/) and the genotype distri-
bution in the control population was in Hardy-
Weinberg equilibrium (HWE). None of the three 
tagSNPs showed a statistically significant asso-
ciation with CRC (Table 5). The results were ad-
justed for age and gender due to significant 
difference in the median age and gender distri-
bution among the case and the control group 
(Table 1). The imputation of genotypes based on 
HapMap data did not reveal any SNP to be as-
sociated with the risk of CRC.  
 
Joint analysis of the two sample sets 
 
The allele frequencies of the three tagSNPs 
genotyped in the two populations did not differ 
significantly between the two control groups. For 
two tagSNPs, the ORs were increased for the 
same genotypes in both the Czech and the Ger-
man population (Table 5). The joint anlysis indi-
cated a statistically significant association of 
rs2344481 with an OR of 1.32 (95% CI 1.05-
1.66, dominant model) and of rs2235460 with 
an OR of 1.31 (95% CI 1.04-1.66, AA vs GG) 
after adjustment of the data for age, gender and 




In this study, we found that polymorphisms in 
CTNNBL1 may be associated with CRC risk. In 
particular, tagSNP rs2344481 showed a statis-
tically significant association with CRC in the 
Czech population before and after we adjusted 
the data for age, gender and BMI. The increased 
risk was conferred by the ancestral G allele of 
the polymorphism. This result was supported by 
imputation based on the HapMap data [24] 
which additionally revealed three SNPs up- and 
downstream CTNNBL1 to be associated with 
CRC. All three SNPs are in high LD with 
rs2344481. In contrast, no statistically signifi-
cant association was found for familial/early 
onset CRC of German origin, although in the 
joint analysis of the two populations the asso-
ciation remained statistically significant. The 
results may indicate that the SNPs in CTNNBL1 
are associated with the risk of non-familial, spo-
radic CRC or they may reflect the different geo-
graphical origins of the study populations. How-
ever, the different geographical origin of the 
study populations may play only a subordinate 
role for interpreting the results. Recent studies 
have shown that, regarding SNPs, the auto-
somal gene pool in Europe is relatively homoge-
neous with a slightly distinct gradient in the 
North-South direction [39, 40]. In addition, mi-
crosatellite data have shown that genetic make-
up of the Czech and German population does 
not differ significantly [41]. Accordingly, the two 
sample populations may be attributed as cen-
tral European without a significant stratification 
according to their geographic origin. Thus, the 
partly discordant association observed in the 
German and the Czech sample set might more 
probably be attributed to the different etiology 
of familial/early onset versus non-familial CRC, 
respectively.  
 
The results may also indicate a chance finding, 
because the detected effect would have been 
lost in multiple comparison correction. However, 
considering the previously reported association 
of several SNPs in the CTNNBL1 with obesity 
[9,12,13], the ancestral nature of  the risk al-
leles, and the fact that the gene itself may have 
been a target of positive selection, a true nature 
of the modest effect cannot be excluded. 
 
The previously reported associations of SNPs in 
CTNNBL1 with an increased risk of obesity, in-
creased BMI and fat mass [9, 12, 13], is also 
conferred by the ancestral alleles as the risk 
alleles (OR ~1.3). The same SNPs are in high LD 
(r²≥0.85) with the SNP rs2344481 which 
showed the most significant association with 
CRC in the present study. The non-existing dif-
ferences in the median BMI of the Czech case 
and control population may be due to the fact 
that the blood samples and the anthropometric 
data were collected from the CRC patients at 
the time of diagnosis and the controls were indi-
viduals with gastrointestinal complaints, which 
might have influenced the patient’s weight even 
before it was measured for this study. 
 
Combining the results, it is reasonable that 
CTNNBL1, particularly rs2344481 and its linked 
SNPs, might play a role in at least two nutrition-
related complex diseases. There is strong evi-
dence that nutrition-related complex diseases 
can be associated with an ancestral risk allele 
[16].  In this study, we used data derived from 
several databases, statistical tests, and phy-
logenetic analyses, which consistently pointed 
to a likely shaping of CTNNBL1 by positive selec-
tion. First, the distinct change in the frequency 
of the ancestral alleles (up to more than 50% 
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differences from YRI to CEU and to CHB/JPT), 
found in several SNPs captured by rs2344481, 
indicated that a selective process could have 
driven the development of the gene [42, 43]. 
Second, statistically significant fixation indices 
(FST) supported the assumption that positive 
selection has shaped CTNNBL1 [33, 34, 44]. 
The same applies for the observed combination 
of extreme standardized integrated haplotype 
scores (|iHS|) and strongly negative values of 
Fay and Wu’s H for several SNPs captured in 
our study [36]. A comparison of approximately 
800.000 SNPs has shown that a high |iHS| 
>2.5 corresponds to the most extreme 1% of 
the iHS values. The proportion of |iHS| >2 is 
higher in genic than in non-genic SNPs, showing 
varying values in different population (1.23 in 
YRI, 1.16 in CEU, 1.13 in CHB/JPT)[36]. Further-
more, the strong linkage disequilibrium and the 
low recombination rate implied a high intras-
pecific conservation of CTNNBL1. At the same 
time, the human-mouse alignment indicated a 
high interspecific conservation within the whole 
gene region, including coding and non-coding 
sequences. In the human-mouse alignments, 
the coding regions of genes are well conserved 
in general, while intronic regions tend to be the 
least conserved feature type of non-coding but 
intergenic sequences, showing an average of 
23% identity [45]. Interestingly, CTNNBL1 
shows both features of interspecific and intras-
pecific conservation encompassing the whole 
gene region. The findings were supported by the 
results of the phylogenetic analyses to the cod-
ing and non-coding sequences of CTNNBL1. The 
sequence differences of both the cDNA and 
intronic DNA of CTNNBL1 were species specific 
and allowed construction of phylogenetic trees 
that reflected one of the today's valid phyloge-
netic trees of animals quite well. Studies have 
shown that conserved non-genic sequences are 
an unexpected feature of mammalian genomes 
[46] and that the phylogenetic performance of 
single genes is highly variable [47, 48].  
 
The characteristics of CTNNBL1 and the asso-
ciation of the ancestral alleles of several SNPs 
in this gene with CRC and obesity indicate that 
the ancestral susceptibility model may apply to 
this gene. As the actual function of CTNNBL1 
remains unknown, one may speculate that both 
an adaptation to a new dietary composition and 
an adaptation of the immune system for the 
new requirements of the environment are possi-
ble triggers of the positive selection in CTNNBL1 
[9, 48, 49]. The fact that the associated SNP 
was non-coding or that CRC is a late-onset dis-
ease does not negate the hypothesis. Several 
functional non-protein-coding DNA sequences, 
such as cis-regulatory sequences [50] and 
miRNAs [51], are known to be targets of selec-
tion. Polymorphisms associated with multifacto-
rial traits are often located in non-coding se-
quences, such as in regulatory sequences, 3' 
untranslated regions, introns or intergenic se-
quences of unknown transcriptional status [52]. 
Especially the new discoveries in the field of 
epigenetics highlight the role of non-coding DNA 
sequences in regulatory processes and associa-
tions of polymorphisms in these regions with 
complex diseases [52]. It should also be consid-
ered that the detected SNP may be linked to a 
still unknown functional variant as the actual 
target of selection, or that the SNP itself may 
have a so far unknown regulatory function. Fur-
thermore, it has to be taken into account that 
the CRC itself may not have been the trigger of 
the selection but a so far unknown trait. Accord-
ingly, a mutation leading to a primary effect late 
in life may have a weak deleterious effect early 




In conclusion, our study suggests that polymor-
phisms in CTNNBL1 may be associated with 
CRC, possibly through a gene-environment inter-
action. Carriers of the ancestral G allele in 
rs2344481 had an increased risk of CRC. The 
effect was more prominent in the hospital-
based Czech sample population than in the 
family/early onset-based German sample popu-
lation. Additionally, we showed that CTNNBL1 
was shaped by positive selection. Further stud-
ies are needed to identify the actual function of 
CTNNBL1, to define the selective trait and to 
validate our results in other sample populations. 
The analysis of the relationship between 
CTNNBL1, CRC and other nutrition related dis-
eases may provide further insights into the evo-
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